|
|
| | H-Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val-OH Basic information |
| Product Name: | H-Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val-OH | | Synonyms: | PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL;MAGE-3 Antigen (271-279) (huMan)
MelanoMa-Associated Antigen 3 (271-279) (huMan);PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL: FLWGPRALV;FLWGPRALV;MELANOMA-ASSOCIATED ANTIGEN 3 (271-279) (HUMAN);MAGE-3 (271-279);MAGE-3 HUMAN (271-279);MAGE-3 ANTIGEN (271-279) (HUMAN) | | CAS: | 160295-81-8 | | MF: | C53H79N13O10 | | MW: | 1058.28 | | EINECS: | | | Product Categories: | Peptide | | Mol File: | 160295-81-8.mol |  |
| | H-Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val-OH Chemical Properties |
| density | 1.36±0.1 g/cm3(Predicted) | | storage temp. | -15°C | | pka | 3.37±0.10(Predicted) | | Sequence | Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val |
| | H-Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val-OH Usage And Synthesis |
| Uses | MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta[1]. | | References | [1] J Herman, et al. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics. 1996;43(6):377-83. DOI:10.1007/BF02199806 |
| | H-Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val-OH Preparation Products And Raw materials |
|